GSK
(LSE) GSK
GSK Financials at a Glance
Market Cap
$7.83T
Revenue (TTM)
$32.67B
Net Income (TTM)
$5.72B
EPS (TTM)
$139.00
P/E Ratio
13.88
Dividend
$66.00
Beta (Volatility)
0.02 (Low)
Dividend
$66.00
Beta (Volatility)
0.02 (Low)
Price
$1950.50
Volume
14,988,736
Open
$1960.00
Price
$1950.50
Volume
14,988,736
Open
$1960.00
Previous Close
$1950.50
Daily Range
$1940.50 - $1967.50
52-Week Range
$1242.50 - $2282.00
Dividend
$66.00
Beta (Volatility)
0.02 (Low)
Price
$1950.50
Volume
14,988,736
Open
$1960.00
Previous Close
$1950.50
Daily Range
$1940.50 - $1967.50
52-Week Range
$1242.50 - $2282.00
GSK News
Sex, Drugs, and China Woes
GSK: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout GSK
Industry
Pharmaceuticals
Sector
Health CareEmployees
66,841
CEO
Emma N. Walmsley
Website
www.gsk.comHeadquarters
Brentford, TW8 9GS, GB
GSK Financials
Key Financial Metrics (TTM)
Gross Margin
72%
Operating Margin
22%
Net Income Margin
17%
Return on Equity
38%
Return on Capital
18%
Return on Assets
9%
Earnings Yield
7.20%
Dividend Yield
0.03%
Payout Ratio
44.86%
Stock Overview
Market Cap
$7.83T
Shares Outstanding
4.00B
Volume
14.99M
Short Interest
0.00%
Avg. Volume
8.57M
Financials (TTM)
Gross Profit
$23.70B
Operating Income
$7.17B
EBITDA
$11.88B
Operating Cash Flow
$7.30B
Capital Expenditure
$1.35B
Free Cash Flow
$5.96B
Cash & ST Invst.
$3.41B
Total Debt
$17.72B
GSK Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.62B
+6.2%
Gross Profit
$5.98B
+7.2%
Gross Margin
69.38%
N/A
Market Cap
$7.83T
N/A
Market Cap/Employee
$114.11M
N/A
Employees
68,629
N/A
Net Income
$636.00M
+53.6%
EBITDA
$2.20B
+38.9%
Quarterly Fundamentals
Net Cash
$14.31B
-7.9%
Accounts Receivable
$7.76B
+11.9%
Inventory
$5.92B
+4.5%
Long Term Debt
$14.71B
+0.5%
Short Term Debt
$3.01B
+19.7%
Return on Assets
9.35%
N/A
Return on Invested Capital
18.05%
N/A
Free Cash Flow
$1.52B
+27.1%
Operating Cash Flow
$2.09B
-10.3%